CARDAMYST

This brand name is authorized in United States.

Active ingredients

The drug CARDAMYST contains one active pharmaceutical ingredient (API):

1	Etripamil UNII S82A18Y42P - ETRIPAMIL
	Etripamil is an L-type calcium influx inhibitor (slow channel blocker or calcium ion antagonist). Etripamil exerts its pharmacologic effect by modulating the influx of ionic calcium across the cell membrane of the AV nodal cells as well as arterial smooth muscles and contractile myocardial cells. By interrupting reentry at the AV node, etripamil can restore sinus rhythm in patients with PSVT.
	Read more about Etripamil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CARDAMYST Nasal spray	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08DA03		C Cardiovascular system → C08 Calcium channel blockers → C08D Selective calcium channel blockers with direct cardiac effects → C08DA Phenylalkylamine derivatives
Discover more medicines within C08DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	83468-070